Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Hamilton Health Sciences Ajinomoto USA, INC. |
---|---|
Information provided by: | McMaster University |
ClinicalTrials.gov Identifier: | NCT00692601 |
Capsiate is a non-pungent analogue of capsaicin, the component of hot peppers that makes them hot or spicy. Unlike capsaicin, capsiate is not spicy or hot. Ingestion of capsiate has been shown to increase resting oxygen consumption, body temperature, and the burning of fat. As such, capsiate appears to act in a manner similar to that of many other substances that energize us, increase our alertness and cause a rushing feeling by affecting a system in our body that is responsible for the release of adrenaline. The major difference, however, is that capsiate is broken down in the stomach into two components: vanilla and a fatty acid, and is not absorbed as capsiate into the blood stream at all. This implies that the way capsiate works is likely by acting on the cells in the gut (before it is broken down)rather than affecting all other cells in the body as it would do if it ended up in the blood. Therefore, the gut cells are thought to be the ones responsible for triggering the full-body adrenaline response. In any case, the use of capsiate has been shown to be effective in preventing weight gain and as such it may represent a possible therapy for treating obesity. Many obesity-related programs not involving medication advocate the use of diet and/or exercise. However, one of the biggest problems with weight loss from dieting alone is a general decrease in our body's ability to burn the food we eat as energy. This very problem is the reason for why people turn to adrenaline-releasing drugs like caffeine and ephedra. Unfortunately though, if too much is consumed, there is a high risk of bad side-effects. However, low dose caffeine/ephedra compounds (that are within specified FDA limits) have recently been reported to be effective. Moreover, these compounds are used with great frequency by people attempting to lose weight.
Given that capsiate increases body temperature, promotes the burning of body fat and has an exceptionally great side-effect profile, it looks to be a very effective supplement for use in treatment of obesity and overweight. As such, it would be important to test this supplement along with exercise. This is because consuming capsiate with exercise may enhance its effectiveness in increasing the burning of body fat. The primary purpose of this study is to examine the response of young healthy males to a 90 minute bout of moderate intensity cycling after having consumed 0 mg, 3 mg, or 10 mg of capsiate.
Condition | Intervention | Phase |
---|---|---|
Healthy |
Dietary Supplement: Acute consumption of Capsiate Natura Dietary Supplement: Acute ingestion of identical placebo capsules |
Phase I |
Study Type: | Interventional |
Study Design: | Basic Science, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Placebo Control, Crossover Assignment, Safety/Efficacy Study |
Official Title: | Effect of Differing Doses of A Sweet Pepper Extract - Capsiate (A Capsaicin Analogue) - On Energy Expenditure and Blood Parameters in Humans During Exercise |
Enrollment: | 12 |
Study Start Date: | April 2008 |
Study Completion Date: | September 2008 |
Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
acute oral ingestion of 3 mg capsiate
|
Dietary Supplement: Acute consumption of Capsiate Natura
10 capsules = 3 mg total capsiate. Consumed ONCE orally as capsules 30 minutes before starting to exercise. 3 active capsules containing 1 mg capsiate each and 7 placebo capsules.
|
2: Experimental
acute oral ingestion of 10 mg capsiate
|
Dietary Supplement: Acute consumption of Capsiate Natura
10 capsules = 10 mg total capsiate. Consumed ONCE orally as capsules 30 minutes before starting to exercise. Each capsule contains 1 mg capsiate.
|
3: Placebo Comparator
acute oral ingestion of 0 mg capsiate ( same number of capsules as two other trials and identical looking placebo capsules)
|
Dietary Supplement: Acute ingestion of identical placebo capsules
10 mg placebo = 0 mg total capsiate. Consumed ONCE orally as capsules 30 minutes before starting to exercise. Each capsule contains 1 mg capsiate.
|
Ages Eligible for Study: | 18 Years to 30 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Canada, Ontario | |
Exercise Metabolism Research Laboratory, McMaster Univeristy | |
Hamilton, Ontario, Canada, L8S 4K1 |
Principal Investigator: | Stuart M Phillips, Ph.D. | Department of Kinesiology, McMaster University |
Study Director: | Andrea R Josse, M.Sc. | Department of Kinesiology, McMaster University |
Study Director: | Nicholas A Burd, M.Sc. | Department of Kinesiology, McMaster University |
Study Chair: | Yoshiyuki Fujishima, D.Phil. | Ajinomoto USA, INC. |
Responsible Party: | Department of Kinesiology, McMaster University ( Stuart M Phillips, Associate Professor ) |
Study ID Numbers: | REB 07-410, NHPD#:130269 |
Study First Received: | June 4, 2008 |
Last Updated: | September 15, 2008 |
ClinicalTrials.gov Identifier: | NCT00692601 |
Health Authority: | Canada: Health Canada |
Acute Exercise protocol Crossover design Oxygen consumption (VO2) Respiratory Exchange Ratio (RER) |
Adrenergic System Agonism Capsiate Natura Young Male |
Healthy Capsaicin |